Inqovi plus venetoclax cleared for AML ineligible for intensive chemo

What this means

Inqovi is a combination pill that contains two drugs: decitabine, which interferes with cancer cell growth, and cedazuridine, which helps decitabine stay active in the body longer. Today FDA approved Inqovi to be used alongside venetoclax for adults with acute myeloid leukemia who cannot tolerate intensive chemotherapy. This approval gives these patients a new treatment option that may help manage their cancer with a less intensive approach.